Short answer
Perspective Therapeutics, Inc. (CATX) filed an 8-K current report with the SEC on May 22, 2026 reporting Item 8.01 (Other Events). Interim clinical-trial results presented at 2026 ASCO, a key oncology data catalyst.
Perspective Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Interim clinical-trial results presented at 2026 ASCO, a key oncology data catalyst
- Results may influence investor views on Perspective’s therapeutic pipeline and future development priorities
- Press release dated May 21, 2026 contains the substantive trial findings and is filed as Exhibit 99.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Perspective Therapeutics, Inc. 8-K filings
Get the next CATX 8-K as it lands
Follow CATX for push alerts, or ask the research agent what this filing means.